On 13 February 2016
Biofil Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 February 2016, to consider and approve the un-audited financial Result for the 3rd Quarter ended on 31 December 2015 along with limited review report, & to consider and accept the resignation letter from existing Company Secretary and Compliance Officer and appointment of new Company secretary and compliance officer in place of existing Company secretary and Compliance officer.Powered by Capital Market - Live News